Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-06 10:29 am Purchase | 2023-12-31 | 13G | Palisade Bio, Inc. PALI | Mitchell P. Kopin | 12,035 1.900% | 3,296 (+37.72%) | Filing History |
| 2024-02-06 10:27 am Sale | 2023-12-31 | 13G | Kiora Pharmaceuticals, Inc. KPRX | Mitchell P. Kopin | 13,012 1.500% | -6,185 (-32.22%) | Filing History |
| 2024-02-06 10:24 am Unchanged | 2023-12-31 | 13G | NAYA Biosciences, Inc. NAYA | Mitchell P. Kopin | 15,333 6.900% | 0 (Unchanged) | Filing History |
| 2024-02-06 10:24 am Purchase | 2023-12-31 | 13G | Performance Shipping Inc. PSHG | Mitchell P. Kopin | 472,800 3.900% | 206,134 (+77.30%) | Filing History |
| 2024-02-06 10:23 am Sale | 2023-12-31 | 13G | Petros Pharmaceuticals, Inc. PTPI | Mitchell P. Kopin | 6,191 6.600% | -495 (-7.40%) | Filing History |
| 2024-02-06 10:22 am Purchase | 2023-12-31 | 13G | Helius Medical Technologies, Inc. HSDT | Mitchell P. Kopin | 1 0.100% | 1 (New Position) | Filing History |
| 2024-02-06 10:19 am Purchase | 2023-12-31 | 13G | Guardion Health Sciences, Inc. GHSI | Mitchell P. Kopin | 50,000 3.800% | 50,000 (New Position) | Filing History |
| 2024-02-06 10:17 am Sale | 2023-12-31 | 13G | Enveric Biosciences, Inc. ENVB | Mitchell P. Kopin | 644 6.200% | -272 (-29.66%) | Filing History |
| 2024-02-06 10:16 am Purchase | 2023-12-31 | 13G | Synaptogenix, Inc. SNPX | Mitchell P. Kopin | 41,929 4.990% | 10,460 (+33.24%) | Filing History |
| 2024-02-06 10:14 am Purchase | 2023-12-31 | 13G | Agile Therapeutics, Inc. AGRX | Mitchell P. Kopin | 23,961 0.900% | 23,961 (New Position) | Filing History |
| 2024-02-06 10:12 am Unchanged | 2023-12-31 | 13G | Tian Ruixiang Holdings Ltd TIRX | Mitchell P. Kopin | 53,667 8.100% | 0 (Unchanged) | Filing History |
| 2024-02-06 10:11 am Purchase | 2023-12-31 | 13G | Antelope Enterprise Holdings Limited AEHL | Mitchell P. Kopin | 2,751 4.990% | 2,751 (New Position) | Filing History |
| 2024-02-06 10:06 am Purchase | 2023-12-31 | 13G | Aditxt, Inc. ADTX | Mitchell P. Kopin | 1 1.500% | 1 (New Position) | Filing History |
| 2024-02-06 10:04 am Unchanged | 2023-12-31 | 13G | DMK Pharmaceuticals Corporation DMKPQ | Mitchell P. Kopin | 650,000 6.000% | 0 (Unchanged) | Filing History |
| 2024-02-06 09:56 am Sale | 2023-12-31 | 13G | PharmaCyte Biotech, Inc. PMCB | Mitchell P. Kopin | 903,412 9.990% | -1,015,547 (-52.92%) | Filing History |
| 2024-02-06 09:52 am Purchase | 2023-12-31 | 13G | Clearmind Medicine Inc. CMND | Mitchell P. Kopin | 88,925 4.990% | 88,925 (New Position) | Filing History |
| 2024-02-02 4:10 pm Purchase | 2024-01-25 | 13G | RedHill Biopharma Ltd. RDHL | Mitchell P. Kopin | 2,000 4.000% | 2,000 (New Position) | Filing History |
| 2023-11-27 06:10 am Purchase | 2023-11-16 | 13G | Bone Biologics Corporation BBLG | Mitchell P. Kopin | 4,676 4.990% | 4,676 (New Position) | Filing History |
| 2023-08-11 4:18 pm Purchase | 2023-08-04 | 13G | NAYA Biosciences, Inc. NAYA | Mitchell P. Kopin | 15,333 7.100% | 15,333 (New Position) | Filing History |
| 2023-08-10 4:03 pm Purchase | 2023-08-01 | 13G | DMK Pharmaceuticals Corporation DMKPQ | Mitchell P. Kopin | 650,000 7.600% | 650,000 (New Position) | Filing History |